2013 - Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases, American Academy of Neurology
2013 - Sedgwick Memorial Medal, American Public Health Association
The scientist’s investigation covers issues in Alzheimer's disease, Dementia, Neuroscience, Pathology and Internal medicine. His Alzheimer's disease research incorporates themes from Positron emission tomography, Neuroimaging and Cognitive decline. The Dementia study combines topics in areas such as Stroke, Hyperintensity, Gerontology and Cohort.
His work carried out in the field of Neuroscience brings together such families of science as Disease and Neurodegeneration. His research integrates issues of Fluorodeoxyglucose and Central nervous system disease in his study of Pathology. His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology, Magnetic resonance imaging and Cardiology.
Alzheimer's disease, Neuroscience, Pathology, Internal medicine and Dementia are his primary areas of study. William J. Jagust works mostly in the field of Alzheimer's disease, limiting it down to topics relating to Positron emission tomography and, in certain cases, Magnetic resonance imaging, as a part of the same area of interest. His work on Neurodegeneration expands to the thematically related Neuroscience.
Pathology is closely attributed to Central nervous system disease in his research. His research in Internal medicine intersects with topics in Endocrinology, Oncology and Cardiology. While the research belongs to areas of Dementia, William J. Jagust spends his time largely on the problem of Hyperintensity, intersecting his research to questions surrounding White matter.
His primary areas of study are Neuroscience, Disease, Pathology, Internal medicine and Neuroimaging. His research on Neuroscience often connects related topics like Tau pathology. His Disease research is multidisciplinary, incorporating elements of Pathological and Atrophy.
His Pathology study combines topics from a wide range of disciplines, such as White matter and Standardized uptake value. His Internal medicine and Alzheimer's disease, Biomarker and Cognitive decline investigations all form part of his Internal medicine research activities. His Dementia research includes themes of Positron emission tomography, Neurology and Cognitive impairment.
His primary scientific interests are in Disease, Internal medicine, Neuroscience, Dementia and Alzheimer's disease. His Disease research is classified as research in Pathology. William J. Jagust has researched Internal medicine in several fields, including Endocrinology, Neuroimaging and Oncology.
His work deals with themes such as Cognition and Cognitive decline, which intersect with Neuroimaging. His Dementia study incorporates themes from Neurology, Neurodegeneration, Geriatric psychiatry and Intensive care medicine. William J. Jagust combines subjects such as Standardized uptake value and Episodic memory with his study of Alzheimer's disease.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R Jack;David S Knopman;William J Jagust;Leslie M Shaw.
Lancet Neurology (2010)
The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease
Marilyn S. Albert;Steven T. DeKosky;Dennis Dickson;Bruno Dubois.
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.
Clifford R Jack;David S Knopman;William J Jagust;Ronald C Petersen.
Lancet Neurology (2013)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack;David A. Bennett;Kaj Blennow;Maria C. Carrillo.
Alzheimers & Dementia (2018)
Alzheimer's Disease Neuroimaging Initiative
Susanne G. Mueller;Michael W. Weiner;Leon J. Thal;Ronald C. Petersen.
Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers
H. C. Chui;J. I. Victoroff;D. Margolin;W. Jagust.
The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
Michael W. Weiner;Michael W. Weiner;Dallas P. Veitch;Paul S. Aisen;Laurel A Beckett.
Alzheimers & Dementia (2012)
Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization.
R. C. Petersen;P. S. Aisen;Laurel A Beckett;M. C. Donohue.
Ways toward an early diagnosis in Alzheimer’s disease: The Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Susanne G. Mueller;Susanne G. Mueller;Michael W. Weiner;Michael W. Weiner;Leon J. Thal;Ronald C. Petersen.
Alzheimers & Dementia (2005)
The Alzheimer's disease neuroimaging initiative
Susanne G. Mueller;Michael W. Weiner;Michael W. Weiner;Leon J. Thal;Ronald C. Petersen.
Neuroimaging Clinics of North America (2005)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: